Rapt Therapeutics, Inc. (RAPT)
58.02
0.00 (0.00%)
USD |
NASDAQ |
Mar 04, 16:00
Rapt Therapeutics Shareholders Equity (Quarterly) : 151.98M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Penumbra, Inc. | 1.428B |
| Amicus Therapeutics, Inc. | 274.24M |
| Disc Medicine, Inc. | 739.83M |
| Amylyx Pharmaceuticals, Inc. | 305.26M |
| Johnson & Johnson | 81.54B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 165.74M |
| Total Liabilities (Quarterly) | 13.76M |
| Debt to Equity Ratio | 0.0171 |
| Current Ratio | 12.04 |
| Net Debt Paydown Yield | 0.15% |